References
- Baine W, Yu W, Summe J, Weis K. Epidemiological trends in the evaluation and treatment of lower urinary tract symptoms in elderly male Medicare patients from 1991 to 1995. J Urol 1998;160:816–20.
- Wasson J, Bubolz T, Lu-Yao G, Walker-Corkery E, Hammond C, Barry M. For the Patient Outcomes Research Team for Prostatic Diseases. Transurethral resection of the prostate among Medicare beneficiaries: 1984 to 1997. J Urol 2000;164:1212–15.
- Sarma A, Jacobson D, McGree M, Roberts R, Lieber M, Jacobsen S. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997. J Urol 2005;173:2048–53.
- Cornu J, Cussenot O, Haab F, Lukacs B. A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines. Eur Urol 2010;58:450–6.
- van Exel N, Koopmanschap M, McDonnell J, Chapple C, Berges R, Rutten F, et al. Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six European countries: report of the TRIUMPH study. Eur Urol 2006;49:92–102.
- Hutchison A, Farmer R, Chapple C, Berges R, Pientka L, Teillac P, et al. Characteristics of patients presenting with LUTS/BPH in six European countries. Eur Urol 2006;50:555–61.
- Litwin M, Saigal C. editors. Urologic diseases in America. Chapter 2: Benign prostatic hypertrophy/lower urinary tract symptoms and bladder stones. NIH publication no. 12-7865 Washington, DC: US Government Printing Office; 2012. p 45–72.
- Izard J, Nickel J. Impact of medical therapy on transurethral resection of the prostate: two decades of change. BJU Int 2011;108:89–93.
- Vela-Navarrete R, Gonzalez-Enguita C, Garcia-Cardoso J, Manzarbeitia F, Sarasa-Corral J, Granizo J. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992–2002). BJU Int 2005;96:1045–8.
- Walsh D, Chang S. Dilemmas in the treatment of urothelial cancers of the prostate. Urol Oncol 2009;27:352–7.
- Choi S, Kim T, Myung S, Moon Y, Kim K, Kim Y, et al. Impact of changing trends in medical therapy on surgery for benign prostatic hyperplasia over two decades. Korean J Urol 2012;53:23–8.
- Long R, Connolly S, Sweeney P. Impact of pharmacotherapy on the incidence of transurethral prostatectomy for benign prostatic hyperplasia and the implications for surgical training. Ir Med J 2012;103:281–2.
- Blomqvist P, Ekbom A, Carlsson P, Ahlstrand C, Johansson J. Benign prostatic hyperplasia in Sweden 1987 to 1994: changing patterns of treatment, changing patterns of costs. Urology 1997;50:214–19.
- Marteinsson V. Transurethral electrovaporization of the prostate: results in the course of five years. Laeknabladid 2005;91:171–5; In Icelandic.
- Jack S, Geirsson G. Changes in treatment and cost of benign prostatic hyperplasia in Iceland. Laeknabladid 2001;87:213–18; In Icelandic.
- Wilson J, Urwin G, Stower M. The changing practice of transurethral prostatectomy: a comparison of cases performed in 1990 and 2000. Ann R Coll Surg Engl 2004;86:428–31.
- Quinlan M, Connolly S, McDermott T. The decline of TURP – an Irish experience. Br J Med Surg Urol 2009;2:185–90.
- Schroeck F, Hollingsworth J, Kaufman S, Hollenbeck B, Wei J. Population based trends in the surgical treatment of benign prostatic hyperplasia. J Urol 2012;188:1837–47.
- Yu X, Elliot S, Wilt T, McBean A. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol 2008;180:241.
- Masumori N, Kamoto T, Seki N, Homma Y; Committee for Clinical Guideline for Benign Prostatic Hyperplasia. Surgical procedures for benign prostatic hyperplasia: a nationwide survey in Japan. Int J Urol 2011;18:166–70.
- Kang J, Min G, Son H, Kim H, Lee H. National-wide data on the treatment of BPH in Korea. Prostate Cancer Prostatic Dis 2011;14:243–7.
- Malaeb B, Yu X, McBean A, Elliott S. National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000–2008). Urology 2012;79:1111–16.
- Eberth B, Watson V, Ryan M, Hughes J, Barnett G. Does one size fit all? Investigating heterogeneity in men's preferences for benign prostatic hyperplasia treatment using mixed logit analysis. Med Decis Making 2009;29:707–15.
- Takeuchi M, Masumori N, Tsukamoto T. Contemporary patients with LUTS/BPH requiring prostatectomy have long-term history of treatment with alpha1-blockers and large prostates compared with past cases. Urology 2009;74:606–9.